Each treatment containing 1 vial - 340 mg of powder and 10 ml of solvent.
AlidyaTM is the first injection device specifically indicated for the prevention and treatments of gynoid lipodystrophy or cellulitis or and other skin issues associated with cellulite.
Composed mainly of amino acids, Alidya reduces the appearance of cellulite and dimpled skin, improving the overall look of the skin while also helping to prevent cellulite from forming after treatment. Treatment with this solution is non-surgical and minimally invasive, and can help patients achieve a smoother, more toned look to their skin.
The action of AlidyaTM are performed using solubilization, and therefore the removal of these extracellular toxic elements, as well as the restoration of normal cell homeostasis, which is clinically translated by an improvement of areas suffering from or predisposed to development of cellulite.
Alidya ® can be used on any area of the body that is prone to cellulite. This is usually the abdominal region, thighs, buttocks and shoulders. The most impressive results from the use of the drug can be achieved in patients who suffer from an early stage of development of cellulite. Age restrictions for the use of the drug does not exist due to the fact that cellulite may develop as in very early adolescence, and later (after pregnancy or during menopause, as a result of taking the drugs).
Alidya Composition:
- Poliaminoacidico D - (+) glucopyranose Α 1-4 glycosidic acid ethylenediaminetetraacetic
- Acid sodium amine
- System buffer with sodium corrector
- Bicarbonate regulator osmolarity Alidya is supplied in a pack with 5 vials each containing 340 mg of powder and 5 vials of 10 ml of solvent.
- ALIDYA is manufactured in Italy by Marllor Biomedical, the manufacturer of Aqualyx.
-
Volume & Packaging: 5 vials x 340mg powder, 5 vials x 10 ml saline solution.